I-HoME for Caregiver Burden
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a program called I-HoME, which uses video visits with a nurse practitioner to assist family caregivers in managing the care and symptoms of loved ones with advanced Alzheimer's Disease or related dementia. The goal is to determine if this approach is practical and helpful for caregivers. Participants should be English-speaking adults caring for someone with advanced dementia symptoms. As an unphased trial, this study offers caregivers a unique opportunity to explore innovative support methods.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the I-HoME intervention is safe for family caregivers?
Research on the I-HoME intervention remains in the early stages, so specific safety data is not yet available. However, this intervention involves video calls with a nurse practitioner, which generally poses low risk. It focuses on managing symptoms and care needs through conversation and guidance. Since I-HoME is neither a drug nor a medical procedure, the risk of side effects is much lower compared to other treatments. Participants can expect a safe and supportive environment designed to help them manage caregiving challenges.12345
Why are researchers excited about this trial?
I-HoME is unique because it offers a personalized approach to managing caregiver burden through video visits with a nurse practitioner. Unlike traditional methods that often rely on in-person consultations, this treatment provides flexibility and convenience by allowing caregivers to receive support and guidance from home. Researchers are excited about this method because it could improve access to care, reduce stress for caregivers, and tailor interventions to specific needs, potentially leading to better outcomes for both caregivers and those they care for.
What evidence suggests that the I-HoME intervention is effective for reducing caregiver burden in advanced Alzheimer's Disease?
Initial findings suggest that the I-HoME program, which participants in this trial will receive, could help reduce stress for caregivers of patients with advanced Alzheimer's disease and related dementia. Research has shown that caregivers often experience anxiety and depression, with about 28.60% facing these mental health issues. I-HoME includes video calls with a nurse practitioner to help manage symptoms and care needs. By addressing these challenges, the program aims to reduce caregiver stress, potentially improving their mental health and quality of life.23467
Who Is on the Research Team?
Veerawat Phongtankuel, MD
Principal Investigator
Weill Medical College of Cornell University
Are You a Good Fit for This Trial?
This trial is for family caregivers of patients with advanced Alzheimer's Disease and related dementias. It aims to support them in managing end-of-life issues using a technology-based intervention called I-HoME.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive video visits with a nurse practitioner for up to six visits every 2 weeks to address symptom management and care needs
Follow-up
Participants are monitored for changes in caregiver anxiety, burden, perception of patient's pain, and behavioral symptoms of dementia
What Are the Treatments Tested in This Trial?
Interventions
- I-HoME
Find a Clinic Near You
Who Is Running the Clinical Trial?
Weill Medical College of Cornell University
Lead Sponsor
National Institute on Aging (NIA)
Collaborator